Published on : Aug 08, 2017
Albany, New York, August 8, 2017: In recent years, data indicating that typhoid fever is a major cause of illness among the urban and peri-urban populations. Typhoid fever is still common in the evolving world, where it affects about 21.5 million individuals each year. Looking to this rising prevalence, a new study covering diagnosed patterns, treatment trends, unmet medical needs and current developments for Typhoid Fever has been added to the vast portfolio of Market Research Hub (MRH), which is titled as “Typhoid Fever-Market Insights, Epidemiology and Market Forecast-2025”. In this study, epidemiology, pathogenesis, clinical manifestations, and diagnosis of typhoid fever are discussed separately.
At first, the report begins with typhoid fever overview, symptoms, staging, diagnosis, treatment and pathophysiology. Typhoid fever is a spreadable infection of the intestines that affects the whole body. It has been analyzed that currently, Typhoid fever, which is caused by Salmonella enterica serotype typhi, remains an important worldwide cause of morbidity and mortality. Recent estimates indicate that there may be at least 21.7 million typhoid cases annually. However, the global mortality estimates of about 200,000 deaths have been revised 3-fold downward from previous evaluations. Clinical diagnosis of typhoid is not specific because the presenting signs and symptoms are diverse and similar to those of other common febrile illnesses, such as malaria and dengue fever.
Geographically, the report provides an overview of the disease and exhaustive research related to Typhoid Fever for the seven major markets for the study period undertaken from 2015-2025. It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Typhoid Fever for 7 major markets, which are United States, EU 5 (Germany, Spain, Italy, France and the United Kingdom) and Japan. According to analyst’s findings, the forecasted patient population of Typhoid Fever will grow steadily, increasing at a high CAGR from 2015 to 2025. Also, the Typhoid Fever 7MM market size is estimated to reach a high value by the end of 2025.
Moving further, the market outlook also provides an understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. In addition to this, the thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Typhoid Fever are also highlighted. At present, two safe and efficacious typhoid vaccines, the injectable Vi polysaccharide and the oral Ty21a, have been licensed; and new, improved candidate vaccines are currently being tested.
Also, a chapter including marketed products highlights the advantages and disadvantages associated with therapies associated with Typhoid Fever, providing an in-depth analysis of emerging therapies which will create an impact through their launch.
Request a Sample with TOC in a PDF format : http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265936
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org